Anti-IL-17 Antibody Improves Hepatic Steatosis by Suppressing Interleukin-17-Related Fatty Acid Synthesis and Metabolism
Figure 4
Differentially expressed protein spots displayed in 2DE images. Representative 2DE images from: (a) the ALD (4W) group, (b) the ALD (8W) group, (c) the ALD (12W) group, and (d) Anti-IL-17 antibody treated ALD group. Data are representative of three separate experiments.
